Next Article in Journal
Characterization of the Interaction between Eupatorin and Bovine Serum Albumin by Spectroscopic and Molecular Modeling Methods
Next Article in Special Issue
miR-29 Represses the Activities of DNA Methyltransferases and DNA Demethylases
Previous Article in Journal
Modulation of Phytoalexin Biosynthesis in Engineered Plants for Disease Resistance
Previous Article in Special Issue
Serum Metallothioneins in Childhood Tumours — A Potential Prognostic Marker
Article Menu

Export Article

Open AccessArticle
Int. J. Mol. Sci. 2013, 14(7), 14171-14184;

The Tumor Suppressor Roles of miR-433 and miR-127 in Gastric Cancer

School of Computer and Information Technology, College of Life Sciences and Bioengineering, Beijing Jiaotong University, 3 Shangyuan Residence, Haidian District, Beijing 100044, China
Department of Critical Care Medicine (CCM), Peking University People's Hospital, Beijing 100044, China
Institute of Basic Medical Sciences, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing 100005, China
Authors to whom correspondence should be addressed.
Received: 1 April 2013 / Revised: 26 June 2013 / Accepted: 27 June 2013 / Published: 8 July 2013
(This article belongs to the Special Issue Advances in Cancer Diagnosis)
Full-Text   |   PDF [3179 KB, uploaded 19 June 2014]


The discovery of microRNAs (miRNAs) provides a new and powerful tool for studying the mechanism, diagnosis and treatment of human cancers. Currently, the methylation epigenetic silencing of miRNAs with tumor suppressor features by CpG island hypermethylation is emerging as a common hallmark of different tumors. Here we showed that miR-433 and miR-127 were significantly down-regulated in gastric cancer (GC) tissues compared with the adjacent normal regions in 86 paired samples. Moreover, the lower level of miR-433 and miR-127 was associated with pM or pTNM stage in clinical gastric cancer patients. The restored expression of miR-433 and miR-127 in GC cells upon 5-Aza-CdR and TSA treatment suggested the loss of miR-433 and miR-127 was at least partly regulated by epigenetic modification in GC. Furthermore, the ectopic expression of miR-433 and miR-127 in gastric cancer cell lines HGC-27 inhibits cell proliferation, cell cycle progression, cell migration and invasion by directly interacting with the mRNA encoding oncogenic factors KRAS and MAPK4 respectively. Taken together, our results showed that miR-433 and miR-127 might act as tumor suppressors in GC, and it may provide novel diagnostic and therapeutic options for human GC clinical operation in the near future. View Full-Text
Keywords: gastric cancer; miR-433; miR-127; KRAS; MAPK4 gastric cancer; miR-433; miR-127; KRAS; MAPK4
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Supplementary material


Share & Cite This Article

MDPI and ACS Style

Guo, L.-H.; Li, H.; Wang, F.; Yu, J.; He, J.-S. The Tumor Suppressor Roles of miR-433 and miR-127 in Gastric Cancer. Int. J. Mol. Sci. 2013, 14, 14171-14184.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top